← All indications
Plaque, Atherosclerotic
Lesions formed within the walls of ARTERIES associated with deposits of fat and other substances that accumulate in the lining of the artery wall.
Drugs by status
Phase 2 trials (1)
Phase 1 trials (3)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (27)
- Regeneron
- Amgen
- AstraZeneca
- Sanofi
- Kobe University
- CardioVascular Research Foundation, Korea
- Harvard University
- University of Washington
- National Defense Medical College, Japan
- Seoul National University
- Silesian University of Medicine
- Sheffield Hallam University
- University of Toronto
- Westside Medical Associates of Los Angeles
- Peking University
- University of Ulsan
- University of Munster
- Boryung Pharmaceutical Company
- Hanmi Pharmaceutical
- Beijing Clinstech-med consulting Co., Ltd
- Sungkyunkwan University
- Yuhan Pharmaceutical Company
- People's Liberation Army of China
- University of Coimbra
- Canadian Medical and Surgical Knowledge Translation Research Group
- Beijing Sino-Japan Friendship Hospital
- Medical University of Silesia
Organization Involved with Phase 3 Indications (14)
- Boston Scientific Corporation
- Maastricht University
- University of Bern
- University of Vienna
- Universitaets-Herzzentrum
- Touro University
- University of North Carolina at Chapel Hill
- Osato Research Institute
- University of Mauritius
- Mauritius Cardiac Center
- Mauritius Ministry of Health and Quality of Life
- Societe Uniniere de Bois Cheri
- Mauritius Research Council
- Assistance Publique - Hôpitaux de Paris
Organization Involved with Phase 2 Indications (7)
Organization Involved with Other Experimental Indications (6)